A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955

NCT05206604 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-07295324
DRUG: PF-07259955

Sponsor

Pfizer